查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1989009

生物聚合物創新市場預測至2034年：按聚合物類型、原料、應用和地區分類的全球分析

Biopolymer Innovation Market Forecasts to 2034 - Global Analysis By Polymer Type, Source, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球生物聚合物創新市場規模將達到 26 億美元，並在預測期內以 12.0% 的複合年成長率成長，到 2034 年將達到 65 億美元。

生物聚合物創新領域正透過創造環保替代傳統塑膠的材料，改變多個產業結構。科學家正利用植物、藻類和微生物等可再生資源生產高性能生物聚合物，確保其可生物分解並最大限度地減少對環境的影響。這些材料正被應用於包裝、醫療、紡織和汽車等行業，以減少石化燃料的使用和碳排放。目前的研究重點在於提高生物聚合物的強度、耐熱性和多功能性，以滿足產業標準。此外，生物聚合物也被設計用於緩釋製劑和可適應性材料等先進應用，從而在各個市場推動環境責任和技術進步。

根據歐洲生質塑膠協會的數據，全球生質塑膠（包括PLA、PHA、澱粉混合物和生物基PET等生物聚合物）產能預計將從2022年的約220萬噸增加到2027年的約630萬噸，主要受包裝和消費品需求的推動。

包裝產業需求不斷成長

消費者對環保包裝日益成長的需求是生物聚合物市場的主要驅動力。為了最大限度地減少對環境的負面影響，消費者正在尋求可生物分解和可再生包裝方案。生物聚合物因其可堆肥且能保護內容物，正被擴大應用於食品容器、瓶子和包裝材料。企業正在投資研發耐用、經濟高效且具有阻隔性的生物聚合物。法規、政策和企業永續發展目標正在推動環保包裝解決方案的普及。包裝產業對環保材料的關注正在推動生物聚合物創新市場的發展，使其成為全球成長和在各工業領域廣泛應用的關鍵因素。

高昂的生產成本

生物聚合物生產高成本，是限制市場成長的主要障礙。與傳統塑膠不同，生物聚合物需要昂貴的原料、複雜的加工流程和大量的研發投入，這限制了其競爭力。擴大生產規模仍然困難重重，而高能耗的生產過程進一步推高了成本。對價格敏感的產業，例如消費品和包裝產業，不願採用這些材料。除非生產技術取得進步，降低成本並提高效率，否則生物聚合物的應用將受到限制，即使對永續替代品的需求持續成長，市場成長也將受到抑制。

醫療和生物醫學領域的成長

在醫療領域，具有生物相容性和環境安全性的生物聚合物展現出巨大的成長潛力。其應用包括藥物遞送控制、組織支架、創傷治療和植入。聚合物設計的創新使得標靶治療和個人化醫療解決方案成為可能。對永續醫療材料日益成長的需求正在催生新的商機。生物技術公司與聚合物研究人員之間的合作正在拓展其潛在應用。隨著全球醫療保健支出不斷成長以及先進醫療技術的日益普及，生物聚合物將在提供創新、安全且環保的醫療解決方案方面發揮關鍵作用。

與傳統塑膠的競爭

由於傳統塑膠具有成本效益高、供應充足和性能穩定等優勢，它們對生物聚合物構成了重大挑戰。習慣使用合成聚合物的產業可能會因為生物聚合物較高的製造成本和有限的規模化生產能力而猶豫是否轉向使用。對成本敏感的產業，例如包裝和消費品產業，往往更傾向於選擇價格較低的材料。現有的傳統塑膠製造、分銷和回收基礎設施進一步鞏固了其強大的市場地位。除非生物聚合物能夠達到與傳統塑膠相當的價格和功能可靠性，否則它們將繼續面臨激烈的競爭，從而阻礙其普及應用並抑制整體市場成長。

新冠疫情的影響：

新冠疫情對生物聚合物市場既有限制性影響，也有刺激性影響。供應鏈中斷、原料短缺和暫時性停產最初導致營運放緩，產品上市延遲。另一方面，疫情也增加了對環保包裝、醫療設備、個人防護工具（PPE）和一次性醫療產品的需求，從而促進了生物聚合物的應用。尤其是在醫療和製藥領域，生物聚合物在醫療設備、植入和藥物傳輸解決方案的應用顯著加速。儘管初期面臨許多困難，但疫情凸顯了對永續和安全材料的需求，最終強化了生物聚合物的戰略重要性，並改善了其長期市場前景。

在預測期內，聚乳酸（PLA）細分市場預計將佔據最大的市場佔有率。

由於聚乳酸（PLA）供應充足、價格適中且應用廣泛，涵蓋包裝、紡織品、醫療和一次性用品等領域，預計在預測期內，PLA將佔據最大的市場佔有率。 PLA源自玉米澱粉和甘蔗等可再生資源，是一種可生物分解且環境友善的材料。其優異的機械性能、易於加工以及與現有生產系統的兼容性使其具有很高的應用價值。消費者環保意識的增強和政府的支持政策進一步推動了對PLA的需求。因此，PLA保持著最大的市場佔有率，並已成為永續創新和全球生物聚合物產業的關鍵材料。

在預測期內，微生物領域預計將呈現最高的複合年成長率。

在預測期內，微生物衍生生物聚合物預計將呈現最高的成長率。這些生物聚合物由細菌、酵母或真菌發酵生產，具有品質穩定、純度高、性能可調等優點，使其適用於生物醫學、包裝和醫療保健等領域。發酵技術、製程最佳化和基因工程的進步正在提高產量、降低生產成本並拓展工業應用。加之市場對永續、可生物分解和高性能材料的需求不斷成長，以及持續的研發投入，微生物衍生生物聚合物正引領全球生物聚合物市場成長，成為成長最快的品類。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這主要得益於其強大的工業基礎、技術進步以及對永續材料的堅定承諾。積極的研究、有利的法規以及消費者對環保產品日益成長的需求，正在鞏固其市場領導地位。該地區擁有許多知名的生物聚合物生產商和完善的供應鏈網路。生物聚合物在包裝、醫療保健、汽車和電子等行業的生產應用正在迅速擴展。持續的創新、對先進生物聚合物解決方案的投資以及對生態系統永續永續性的堅定承諾，將使北美能夠保持其領先地位，並繼續引領全球生物聚合物應用市場。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於工業擴張、人口成長以及對永續解決方案日益成長的需求。政府對環保替代方案的支持以及不斷增強的環保意識是關鍵的成長要素。中國、印度和日本等國家正大力投資研發、生產設施和可再生原料。生物聚合物在亞太地區的包裝、醫療、汽車和紡織業的應用日益廣泛。技術進步、生產效率的提高以及策略聯盟的建立，共同推動了市場的快速發展，使亞太地區成為全球生物聚合物市場成長最快的地區。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章 全球生物聚合物創新市場：依聚合物類型分類

  • 聚乳酸（PLA）
  • 聚羥基烷酯（PHA）
  • 澱粉基生物聚合物
  • 纖維素基生物聚合物
  • 蛋白質衍生的生物聚合物
  • 新興生物聚合物

第6章 全球生物聚合物創新市場：依來源分類

  • 植物來源原料
  • 微生物來源
  • 海洋來源
  • 源自廢棄物

第7章 全球生物聚合物創新市場：依應用領域分類

  • 包裝
  • 農業
  • 醫療保健
  • 消費品（包裝除外）
  • 汽車和電子
  • 建築材料

第8章 全球生物聚合物創新市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第9章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第10章：產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第11章：公司簡介

  • NatureWorks
  • BASF
  • Corbion
  • Mitsubishi Chemical Corporation
  • Novamont
  • Danisco（DuPont Nutrition & Biosciences）
  • Braskem
  • Biome Bioplastics
  • Arkema
  • Synbra Technology
  • Ticona（Celanese）
  • Futerro
  • Plantic Technologies
  • Avantium
  • DIC Corporation
  • Sulapac
  • Danimer Scientific
  • BIOTEC
Product Code: SMRC34298

According to Stratistics MRC, the Global Biopolymer Innovation Market is accounted for $2.6 billion in 2026 and is expected to reach $6.5 billion by 2034 growing at a CAGR of 12.0% during the forecast period. The field of biopolymer innovation is reshaping multiple sectors by creating eco-friendly substitutes for traditional plastics. Scientists are producing high-performance biopolymers from renewable sources like plants, algae, and microbes, ensuring biodegradability and minimal environmental impact. These materials are being adopted in packaging, healthcare, textiles, and automotive industries to cut fossil fuel use and carbon emissions. Efforts emphasize enhancing strength, heat resistance, and versatility to satisfy industrial standards. Moreover, biopolymers are being designed for advanced applications, including controlled drug release and adaptive materials, promoting both environmental responsibility and technological progress across various markets.

According to the European Bioplastics Association, global production capacity for bioplastics (which includes biopolymers such as PLA, PHA, starch blends, and bio-based PET) is projected to increase from around 2.2 million tonnes in 2022 to approximately 6.3 million tonnes by 2027, driven largely by packaging and consumer goods demand.

Market Dynamics:

Driver:

Rising demand in packaging industry

The growing trend toward green packaging is a major market driver for biopolymers. Consumers seek biodegradable and renewable packaging options to minimize environmental harm. Biopolymers are increasingly used in food containers, bottles, and wraps due to compostability and protection of contents. Companies invest in durable, cost-effective biopolymers with strong barrier properties. Policy regulations and corporate sustainability goals support the adoption of eco-friendly packaging solutions. The packaging sector's emphasis on environmentally responsible materials is fueling the biopolymer innovation market, positioning it as a key factor in global growth and widespread industrial application.

Restraint:

High production costs

The elevated costs associated with biopolymer production act as a key barrier to market growth. Unlike traditional plastics, biopolymers demand costly raw materials, advanced processing methods, and significant research investment, limiting competitiveness. Scaling up production remains challenging, and energy-intensive manufacturing processes further increase expenses. Price-sensitive sectors, such as consumer goods and packaging, hesitate to adopt these materials. Unless production technologies advance to reduce costs and enhance efficiency, the broader acceptance of biopolymers will be constrained, restraining market growth even as demand for sustainable alternatives continues to rise.

Opportunity:

Growth in healthcare and biomedical applications

The healthcare sector offers substantial growth prospects for biopolymers due to their compatibility with the human body and environmentally safe characteristics. Applications include controlled drug delivery, tissue scaffolding, wound healing, and implants. Innovations in polymer design allow targeted treatments and personalized healthcare solutions. Rising demand for sustainable medical materials opens new business opportunities. Partnerships between biotech companies and polymer researchers are expanding potential uses. As global healthcare spending increases and advanced medical technologies gain traction, biopolymers can play a crucial role in delivering innovative, safe, and eco-friendly healthcare solutions.

Threat:

Competition from conventional plastics

Traditional plastics remain a major challenge for biopolymers due to their cost-effectiveness, widespread availability, and consistent performance. Industries familiar with synthetic polymers may hesitate to switch because of higher production costs and limited scalability of biopolymers. Cost-conscious sectors, like packaging and consumer products, often prefer cheaper materials. Existing infrastructure for manufacturing, distributing, and recycling conventional plastics reinforces their market stronghold. Unless biopolymers achieve comparable affordability and functional reliability, they will continue facing stiff competition, hindering widespread adoption and restraining overall market growth.

Covid-19 Impact:

The Covid-19 outbreak had both constraining and stimulating effects on the biopolymer market. Supply chain interruptions, limited raw materials, and temporary production shutdowns initially slowed operations and postponed product introductions. Conversely, the crisis increased demand for eco-friendly packaging, medical equipment, PPE, and disposable healthcare products, driving biopolymer adoption. The medical and pharmaceutical sectors notably accelerated usage in devices, implants, and drug delivery solutions. Despite early setbacks, the pandemic underscored the necessity for sustainable and safe materials, ultimately reinforcing the strategic importance of biopolymers and enhancing their long-term market prospects.

The polylactic acid (PLA) segment is expected to be the largest during the forecast period

The polylactic acid (PLA) segment is expected to account for the largest market share during the forecast period due to its abundant availability, affordability, and broad industrial applications, including packaging, textiles, healthcare, and disposable products. Sourced from renewable materials like corn starch and sugarcane, PLA is biodegradable and eco-friendly. Its strong mechanical characteristics, ease of processing, and compatibility with existing production systems make it highly adoptable. Rising environmental awareness among consumers and supportive government policies further drive PLA demand. As a result, PLA maintains the largest market share, establishing itself as a cornerstone for sustainable innovation and a key material in the global biopolymer industry.

The microbial-derived segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the microbial-derived segment is predicted to witness the highest growth rate. Produced via bacterial, yeast, or fungal fermentation, these biopolymers provide consistent quality, high purity, and tunable properties suitable for biomedical, packaging, and healthcare applications. Advances in fermentation technology, process optimization, and genetic engineering are enhancing yields, lowering production costs, and broadening industrial use. Rising demand for sustainable, biodegradable, and high-performance materials, coupled with continuous research and development efforts, is propelling the microbial-derived segment as the highest growth rate contributor and the most rapidly expanding category in the global biopolymer market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by a robust industrial framework, technological advancements, and a strong preference for sustainable materials. Active research, supportive regulations, and growing consumer demand for environmentally friendly products reinforce market leadership. The region hosts prominent biopolymer manufacturers and well-established supply networks. Industries like packaging, healthcare, automotive, and electronics are increasingly utilizing biopolymers in production. Persistent innovation, investment in advanced biopolymer solutions, and emphasis on ecological sustainability enable North America to maintain its top position and lead the global market in biopolymer adoption.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by industrial expansion, rising population, and increased demand for sustainable solutions. Government support for eco-friendly alternatives and growing environmental awareness are key growth factors. Countries including China, India, and Japan are heavily investing in R&D, production facilities, and renewable feedstocks. The region's packaging, healthcare, automotive, and textile industries are increasingly adopting biopolymers. Advancements in technology, improved production efficiency, and strategic collaborations contribute to rapid market development, positioning Asia-Pacific as the region with the highest growth rate in the global biopolymer market.

Key players in the market

Some of the key players in Biopolymer Innovation Market include NatureWorks, BASF, Corbion, Mitsubishi Chemical Corporation, Novamont, Danisco (DuPont Nutrition & Biosciences), Braskem, Biome Bioplastics, Arkema, Synbra Technology, Ticona (Celanese), Futerro, Plantic Technologies, Avantium, DIC Corporation, Sulapac, Danimer Scientific and BIOTEC.

Key Developments:

In February 2026, DIC Corporation announced that it has established a $62 million investment portfolio to accelerate business creation in the rapidly expanding Physical AI domain, which includes technologies such as sensors, wearables, robotics and automation. As part of this initiative, DIC has entered into a strategic partnership with Emerald Technology Ventures, a Switzerland-based global venture capital firm known for its deep expertise in industrial technologies and strong presence across Europe and North America.

In October 2025, BASF SE and ANDRITZ Group have signed a license agreement for the use of BASF's proprietary gas treatment technology, OASE(R) blue, in a carbon capture project planned to be implemented in the city of Aarhus, Denmark. The project aims to capture approximately 435,000 tons of CO2 annually from the flue gases of a waste-to-energy plant for sequestration; the city of Aarhus has set itself the goal of becoming CO2-neutral by 2030.

In September 2025, Mitsubishi Chemical Corporation has officially announced that it has entered into an Agreement on Coordination and Cooperation for the Maintenance and Development of the Yokkaichi Industrial Complex. This agreement, involves three parties-Mitsubishi Chemical, Mie Prefecture, and Yokkaichi City.

Polymer Types Covered:

  • Polylactic Acid (PLA)
  • Polyhydroxyalkanoates (PHA)
  • Starch-Based Biopolymers
  • Cellulose-Based Biopolymers
  • Protein-Based Biopolymers
  • Emerging Biopolymers

Sources Covered:

  • Plant-Based Feedstock
  • Microbial-Derived
  • Marine-Derived
  • Waste-Derived

Applications Covered:

  • Packaging
  • Agriculture
  • Medical & Healthcare
  • Consumer Goods (Non-Packaging)
  • Automotive & Electronics
  • Construction & Building Materials

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Biopolymer Innovation Market, By Polymer Type

  • 5.1 Polylactic Acid (PLA)
  • 5.2 Polyhydroxyalkanoates (PHA)
  • 5.3 Starch-Based Biopolymers
  • 5.4 Cellulose-Based Biopolymers
  • 5.5 Protein-Based Biopolymers
  • 5.6 Emerging Biopolymers

6 Global Biopolymer Innovation Market, By Source

  • 6.1 Plant-Based Feedstock
  • 6.2 Microbial-Derived
  • 6.3 Marine-Derived
  • 6.4 Waste-Derived

7 Global Biopolymer Innovation Market, By Application

  • 7.1 Packaging
  • 7.2 Agriculture
  • 7.3 Medical & Healthcare
  • 7.4 Consumer Goods (Non-Packaging)
  • 7.5 Automotive & Electronics
  • 7.6 Construction & Building Materials

8 Global Biopolymer Innovation Market, By Geography

  • 8.1 North America
    • 8.1.1 United States
    • 8.1.2 Canada
    • 8.1.3 Mexico
  • 8.2 Europe
    • 8.2.1 United Kingdom
    • 8.2.2 Germany
    • 8.2.3 France
    • 8.2.4 Italy
    • 8.2.5 Spain
    • 8.2.6 Netherlands
    • 8.2.7 Belgium
    • 8.2.8 Sweden
    • 8.2.9 Switzerland
    • 8.2.10 Poland
    • 8.2.11 Rest of Europe
  • 8.3 Asia Pacific
    • 8.3.1 China
    • 8.3.2 Japan
    • 8.3.3 India
    • 8.3.4 South Korea
    • 8.3.5 Australia
    • 8.3.6 Indonesia
    • 8.3.7 Thailand
    • 8.3.8 Malaysia
    • 8.3.9 Singapore
    • 8.3.10 Vietnam
    • 8.3.11 Rest of Asia Pacific
  • 8.4 South America
    • 8.4.1 Brazil
    • 8.4.2 Argentina
    • 8.4.3 Colombia
    • 8.4.4 Chile
    • 8.4.5 Peru
    • 8.4.6 Rest of South America
  • 8.5 Rest of the World (RoW)
    • 8.5.1 Middle East
      • 8.5.1.1 Saudi Arabia
      • 8.5.1.2 United Arab Emirates
      • 8.5.1.3 Qatar
      • 8.5.1.4 Israel
      • 8.5.1.5 Rest of Middle East
    • 8.5.2 Africa
      • 8.5.2.1 South Africa
      • 8.5.2.2 Egypt
      • 8.5.2.3 Morocco
      • 8.5.2.4 Rest of Africa

9 Strategic Market Intelligence

  • 9.1 Industry Value Network and Supply Chain Assessment
  • 9.2 White-Space and Opportunity Mapping
  • 9.3 Product Evolution and Market Life Cycle Analysis
  • 9.4 Channel, Distributor, and Go-to-Market Assessment

10 Industry Developments and Strategic Initiatives

  • 10.1 Mergers and Acquisitions
  • 10.2 Partnerships, Alliances, and Joint Ventures
  • 10.3 New Product Launches and Certifications
  • 10.4 Capacity Expansion and Investments
  • 10.5 Other Strategic Initiatives

11 Company Profiles

  • 11.1 NatureWorks
  • 11.2 BASF
  • 11.3 Corbion
  • 11.4 Mitsubishi Chemical Corporation
  • 11.5 Novamont
  • 11.6 Danisco (DuPont Nutrition & Biosciences)
  • 11.7 Braskem
  • 11.8 Biome Bioplastics
  • 11.9 Arkema
  • 11.10 Synbra Technology
  • 11.11 Ticona (Celanese)
  • 11.12 Futerro
  • 11.13 Plantic Technologies
  • 11.14 Avantium
  • 11.15 DIC Corporation
  • 11.16 Sulapac
  • 11.17 Danimer Scientific
  • 11.18 BIOTEC

List of Tables

  • Table 1 Global Biopolymer Innovation Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Biopolymer Innovation Market Outlook, By Polymer Type (2023-2034) ($MN)
  • Table 3 Global Biopolymer Innovation Market Outlook, By Polylactic Acid (PLA) (2023-2034) ($MN)
  • Table 4 Global Biopolymer Innovation Market Outlook, By Polyhydroxyalkanoates (PHA) (2023-2034) ($MN)
  • Table 5 Global Biopolymer Innovation Market Outlook, By Starch-Based Biopolymers (2023-2034) ($MN)
  • Table 6 Global Biopolymer Innovation Market Outlook, By Cellulose-Based Biopolymers (2023-2034) ($MN)
  • Table 7 Global Biopolymer Innovation Market Outlook, By Protein-Based Biopolymers (2023-2034) ($MN)
  • Table 8 Global Biopolymer Innovation Market Outlook, By Emerging Biopolymers (2023-2034) ($MN)
  • Table 9 Global Biopolymer Innovation Market Outlook, By Source (2023-2034) ($MN)
  • Table 10 Global Biopolymer Innovation Market Outlook, By Plant-Based Feedstock (2023-2034) ($MN)
  • Table 11 Global Biopolymer Innovation Market Outlook, By Microbial-Derived (2023-2034) ($MN)
  • Table 12 Global Biopolymer Innovation Market Outlook, By Marine-Derived (2023-2034) ($MN)
  • Table 13 Global Biopolymer Innovation Market Outlook, By Waste-Derived (2023-2034) ($MN)
  • Table 14 Global Biopolymer Innovation Market Outlook, By Application (2023-2034) ($MN)
  • Table 15 Global Biopolymer Innovation Market Outlook, By Packaging (2023-2034) ($MN)
  • Table 16 Global Biopolymer Innovation Market Outlook, By Agriculture (2023-2034) ($MN)
  • Table 17 Global Biopolymer Innovation Market Outlook, By Medical & Healthcare (2023-2034) ($MN)
  • Table 18 Global Biopolymer Innovation Market Outlook, By Consumer Goods (Non-Packaging) (2023-2034) ($MN)
  • Table 19 Global Biopolymer Innovation Market Outlook, By Automotive & Electronics (2023-2034) ($MN)
  • Table 20 Global Biopolymer Innovation Market Outlook, By Construction & Building Materials (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.